AACR 101st Annual Meeting 2010: NCI/NIH-Sponsored Sessions

NIH Grants: Changes in Review and Funding Opportunities

7:00 a.m.-8:00 a.m.
Chairperson: Suresh Mohla, National Cancer Institute, Division of Cancer Biology, Rockville, MD

• Syed Musaddaq Quadri, IRG/CSR, Bethesda, MD
• Suresh Mohla, NCI-DCB, Rockville, MD

NCI Funding and Training Opportunities in Cancer Research

12:30 p.m.-2:00 p.m.
Chairperson: Jonathan S. Wiest, NCI-CCR-OTE, Bethesda, MD

• Jonathan S. Wiest
• Ming Lei, Center for Cancer Training, NCI, Rockville, MD
• Terry W. Moody, NCI-CCR, Bethesda, MD
• David Nelson, National Cancer Institute, Rockville, MD
• Jackie A. Lavigne, NCI-DCEG, Bethesda, MD

The Cancer Genome Atlas (TCGA) Phase II: Strategy for Comprehensive, Systematic Mapping of 20 Cancers

2:00 p.m.-3:30 p.m.
Chairperson: Anna D. Barker, National Cancer Institute, Bethesda, MD

• Anna D. Barker
• Lynda Chin, Dana-Farber Cancer Institute, Boston, MA
• Joe W. Gray, Lawrence Berkeley National Laboratory, Berkeley, CA
• Richard A. Gibbs, Baylor College of Medicine, Houston, TX
• David Haussler, University of California, Santa Cruz, CA
• Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY
• Joseph G. Vockley, National Cancer Institute, Bethesda, MD
• Bradley A. Ozenberger, National Human Genome Research Institute, Rockville, MD

NCI caHUB: Meeting the Biospecimen Demand for Post-Genomic Cancer Research

3:30 p.m.-4:30 p.m.
Chairperson: Carolyn Compton, National Cancer Institute, Rockville, MD

• Carolyn Compton
• Holly Massett, National Cancer Institute, Rockville, MD
• Elaine Gunter, Specimens Solutions, LLC, Atlanta, GA
• Anne Ashby, Foundation for the National Institutes of Health, Bethesda, MD

Cancer Biomedical Informatics Grid® (caBIG®) Resources to Support Life Sciences and Translational Research

10:15 a.m.-11:45 a.m.
Chairperson: Mervi A. Heiskanen, National Cancer Institute-CB, Rockville, MD

• Mervi A. Heiskanen
• Umit Topaloglu, University of Arkansas, Little Rock, AR
• Juli Klemm, National Cancer Institute, Rockville, MD

New NCI SBIR Bridge Funding Program: Catalyzing Small Business and Investor Partnerships to Develop Cancer Innovations

12:00 p.m.-1:30 p.m.
Chairperson: Michael Weingarten, National Cancer Institute, Bethesda, MD

• Andrew Kurtz, National Cancer Institute, Bethesda, MD
• Michael Weingarten
• Michael Thornton, Endra, Inc., Ann Arbor, MI

Image-Guided Drug Delivery in Cancer: Challenges and Opportunities

1:45 p.m.-3:15 p.m.
Chairperson: Keyvan Farahani, Cancer Imaging Program, National Cancer Institute, Rockville, MD

• Keyvan Farahani
• Gregory Lanza, Washington University, St. Louis, MO
• Crit Moonen, University of Bordeaux, Bordeaux, France
• Anil Patri, NCI/NIH, Frederick, MD

DOD CDMRP-Sponsored Session: Department of Defense Funding Opportunities for Cancer Research

3:30 p.m.-5:30 p.m.
Chairperson: Carolyn J. M. Best, Prostate Cancer Research Program, Frederick, MD

• Elaine Melissa Kaime, Congressionally Directed Medical Research Programs, Frederick, MD
• Frances M. Visco, National Breast Cancer Coalition, Washington, DC
• Gayle G. Vaday, USAMRMC, Fort Detrick, MD
• Arul Chinnaiyan, University of Michigan, Ann Arbor, MI

National Cancer Institute Early Detection Research Network: Advancing Cancer Biomarker Research

10:15 a.m.-11:45 a.m.
Chairperson: Sudhir Srivastava, National Cancer Institute, Rockville, MD

• Jacob Kagan, National Cancer Institute-DCP, Rockville, MD
• David Sidransky, Johns Hopkins Medical Institutions, Baltimore, MD
• Sudhir Srivastava
• Paul D. Wagner, National Cancer Institute, Rockville, MD

National Cancer Institute Symposium on Glycomics for Detection of Cancer and Cancer Risk

11:45 a.m.-1:15 p.m.
Chairperson: Sudhir Srivastava, National Cancer Institute, Rockville, MD

• Karl Krueger, National Cancer Institute, Rockville, MD
• James Michael Pierce, University of Georgia, Athens, GA
• Sudhir Srivastava

Technology Transfer: Financial and Career Opportunities for Researchers

1:30 p.m.-3:30 p.m.
Co-Chairpersons: Phuong Kim Pham, National Institutes of Health, Bethesda, MD, and Eric Hale, National Cancer Institute, Bethesda, MD

• Yvonne Eyler, US Patent and Trademark Office, Alexandria, VA
• Gregory A. Curt, AstraZeneca, Garritt Park, MD
• James A. Fox, Arnold and Porter LLP, Palo Alto, CA
• Eric Hale
• Phuong Kim Pham

NIH Grant Process and Opportunities for Cancer Research Funding at NIH

3:30 p.m.-5:30 p.m.
Co-Chairpersons: Phuong Kim Pham, National Institutes of Health, Bethesda, MD, and Patricia Winkler Carolan, National Cancer Institute, Bethesda, MD 

Download reference documents. (Adobe Acrobat Reader required) 

• William C. Dunty, Jr., National Institutes of Health, Bethesda, MD
• Nancy L. Di Fronzo, National Heart, Lung and Blood Institute, Bethesda, MD
• Suzanne E. Fisher, Center for Scientific Review, Bethesda, MD
• Jane W. Fountain, National Institute of Neurological Disorders and Stroke, Bethesda, MD
• Nancy Lohrey, National Cancer Institute, Bethesda, MD
• Pamela Anne Marino, National Institute of General Medical Sciences, Bethesda, MD
• Yvonne Njage, Fogarty International Center, Bethesda, MD
• Phuong Kim Pham
• Syed Musaddaq Quadri, Center for Scientific Review, Bethesda, MD
• Helen Quill, National Institute of Allergy and Infectious Disease, Bethesda, MD
• Yasaman Shirazi, National Institute of Dental and Craniofacial Research, Bethesda, MD
• Patricia Winkler Carolan

Parlaying the K Award into Your First R01: How Did They Do It?

11:00 a.m.-1:00 p.m.
Co-Chairpersons: Sonia Jakowlew, Cancer Training Branch, Center for Cancer Training, Bethesda, MD, and Nancy Lohrey, Cancer Training Branch, Center for Cancer Training, Bethesda, MD

Speakers
• Li Li, Case Western Reserve University, Cleveland, OH
• H. Charles Manning, Vanderbilt University Medical School, Nashville, TN
• Zdravka O. Medarova, Massachusetts General Hospital, Charlestown, MA
• Robert Prins, University of California, Los Angeles, CA

Panel Participants – NCI Program Directors
• Donald Blair, Cancer Etiology Branch, Division of Cancer Biology, Rockville, MD
• Suzanne Forry-Schaudies, Grants and Contracts Operations Branch, Division of Cancer Treatment and Diagnosis, Rockville, MD
• Yali Fu, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Rockville, MD
• Min Song, Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, Rockville, MD
• John Milner, Nutritional Science Research Group, Division of Cancer Prevention, Rockville, MD
• Barbara Spalholtz, Cancer Cell Biology Branch, Division of Cancer Biology, Rockville, MD